Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cong Claire Xu currently holds 290,154 shares of NovaBridge Biosciences (NBP), valued at approximately $0. This represents their equity stake as SVP, Clinical Development.
Based on SEC Form 4 filings, Cong Claire Xu has been a net seller of NBP stock. They have purchased $0 and sold $13.8K worth of shares.
Cong Claire Xu's most recent insider trade was on Jun 1, 2026, when they sold 3,494 shares at $3.94 per share.
Cong Claire Xu serves as SVP, Clinical Development at NovaBridge Biosciences (NBP). They have executed 3 insider transactions totaling $13.8K over their tenure at the company.
Cong Claire Xu holds the position of SVP, Clinical Development at NovaBridge Biosciences, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Cong Claire Xu has shown a selling trading pattern, with $0 in total purchases and $13.8K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cong Claire Xu was on Jun 1, 2026, when they sold $13.8K worth of NBP shares. This transaction involved 3,494 shares at $3.94 per share.
Cong Claire Xu currently owns 290,154 shares of NovaBridge Biosciences (NBP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cong Claire Xu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cong Claire Xu has 3 Form 4 filings on record as an insider at NovaBridge Biosciences.
Set alerts for Cong Claire Xu and 40,000+ other insiders.